De Domenico P, Gagliardi F, Roncelli F, Snider S, Mortini P
J Neurooncol. 2025; .
PMID: 40080248
DOI: 10.1007/s11060-025-04989-z.
Zhou Y, Wu Y, Zhao X, Xu L, Sun M, Meng Z
Front Immunol. 2025; 16:1515730.
PMID: 39917308
PMC: 11798770.
DOI: 10.3389/fimmu.2025.1515730.
Peng F, Feng Y, Yu S, He R, Wang H, Xie Y
PLoS One. 2024; 19(12):e0314609.
PMID: 39671359
PMC: 11642946.
DOI: 10.1371/journal.pone.0314609.
Zhu D, Du Y, Zhao M, Ablikim D, Huang H, Pan W
Hepatol Int. 2024; 19(1):93-105.
PMID: 39630171
DOI: 10.1007/s12072-024-10753-8.
Chauhan S, Dunn C, Andresen N, Rossevold A, Skorstad G, Sike A
NPJ Breast Cancer. 2024; 10(1):30.
PMID: 38653982
PMC: 11039627.
DOI: 10.1038/s41523-024-00638-2.
A Descriptive, Retrospective Analysis of COVID-19 Passive Antibody Therapy and Its Effects on Morbidity and Mortality in Patients Receiving B-Cell-Depleting Therapies.
Gentile S, Sullivan L, Brooks H, Simeunovic G
Diseases. 2024; 12(2).
PMID: 38391780
PMC: 10887790.
DOI: 10.3390/diseases12020033.
Direct immunoactivation by chemotherapeutic drugs in cancer treatment.
Wang Y, Song Y, He Y, Wang Y, Maurer J, Kiessling F
Adv Ther (Weinh). 2024; 6(12):2300209.
PMID: 38249990
PMC: 7615547.
DOI: 10.1002/adtp.202300209.
Targeting the immune microenvironment for ovarian cancer therapy.
Blanc-Durand F, Clemence Wei Xian L, Tan D
Front Immunol. 2024; 14:1328651.
PMID: 38164130
PMC: 10757966.
DOI: 10.3389/fimmu.2023.1328651.
Multifunctional magnetic nanoparticles elicit anti-tumor immunity in a mouse melanoma model.
Lafuente-Gomez N, de Lazaro I, Dhanjani M, Garcia-Soriano D, Sobral M, Salas G
Mater Today Bio. 2023; 23:100817.
PMID: 37822453
PMC: 10562177.
DOI: 10.1016/j.mtbio.2023.100817.
Conserved and tissue-specific immune responses to biologic scaffold implantation.
DeStefano S, Josyula A, Faust M, Fertil D, Lokwani R, Ngo T
bioRxiv. 2023; .
PMID: 37814705
PMC: 10560402.
DOI: 10.1101/2023.08.15.553390.
Innovative Strategies of Reprogramming Immune System Cells by Targeting CRISPR/Cas9-Based Genome-Editing Tools: A New Era of Cancer Management.
Allemailem K, Alsahli M, Almatroudi A, Alrumaihi F, Al Abdulmonem W, Moawad A
Int J Nanomedicine. 2023; 18:5531-5559.
PMID: 37795042
PMC: 10547015.
DOI: 10.2147/IJN.S424872.
Teleost IgDIgM B cells in gills and skin have a plasmablast profile, but functionally and phenotypically differ from IgMIgD B cells in these sites.
Herranz-Jusdado J, Morel E, Simon R, Diaz-Rosales P, Tafalla C
iScience. 2023; 26(8):107434.
PMID: 37593459
PMC: 10428129.
DOI: 10.1016/j.isci.2023.107434.
Lipid-Polymer Hybrid Nanoparticles Utilize B Cells and Dendritic Cells to Elicit Distinct Antigen-Specific CD4 and CD8 T Cell Responses.
Zhang M, Scotland B, Jiao Y, Slaby E, Truong N, Cottingham A
ACS Appl Bio Mater. 2023; 7(8):4818-4830.
PMID: 37219857
PMC: 10665545.
DOI: 10.1021/acsabm.3c00229.
Recent advances in antigen targeting to antigen-presenting cells in veterinary medicine.
Melgoza-Gonzalez E, Bustamante-Cordova L, Hernandez J
Front Immunol. 2023; 14:1080238.
PMID: 36969203
PMC: 10038197.
DOI: 10.3389/fimmu.2023.1080238.
B cells promote granulomatous inflammation during chronic Mycobacterium tuberculosis infection in mice.
Chen Y, Bharrhan S, Xu J, Sharma T, Wang Y, Salgame P
PLoS Pathog. 2023; 19(3):e1011187.
PMID: 36888692
PMC: 9994760.
DOI: 10.1371/journal.ppat.1011187.
Cell Immunotherapy against Melanoma: Clinical Trials Review.
Filin I, Mayasin Y, Kharisova C, Gorodilova A, Kitaeva K, Chulpanova D
Int J Mol Sci. 2023; 24(3).
PMID: 36768737
PMC: 9916554.
DOI: 10.3390/ijms24032413.
TPC Functions in the Immune System.
Steiner P, Arlt E, Boekhoff I, Gudermann T, Zierler S
Handb Exp Pharmacol. 2023; 278:71-92.
PMID: 36639434
DOI: 10.1007/164_2022_634.
Human B-cell subset identification and changes in inflammatory diseases.
Velounias R, Tull T
Clin Exp Immunol. 2023; 210(3):201-216.
PMID: 36617261
PMC: 9985170.
DOI: 10.1093/cei/uxac104.
Metabolic signatures of immune cells in chronic kidney disease.
Li J, Yang Y, Wang Y, Li Q, He F
Expert Rev Mol Med. 2022; 24:e40.
PMID: 36268748
PMC: 9884772.
DOI: 10.1017/erm.2022.35.
Mesenchymal stromal cells induced regulatory B cells are enriched in extracellular matrix genes and IL-10 independent modulators.
Garcia S, Sandoval-Hellin N, Clos-Sansalvador M, Carreras-Planella L, Moron-Font M, Guerrero D
Front Immunol. 2022; 13:957797.
PMID: 36189264
PMC: 9515545.
DOI: 10.3389/fimmu.2022.957797.